2023 DRG catalog (Fallpauschalen-Katalog) published in Germany

Dec 2022

On November 24, 2022, the INeK (Institute for the Hospital Remuneration System) published the DRG catalog (Fallpauschalen-Katalog) with the list of DRGs and add-on reimbursement categories (ZEs) for 2023. Seven new DRGs and seven ZE categories (for drugs only, none for medical technologies) were added to the catalog in 2023.

Some examples of newly introduced DRGs are provided below:

F77A Complex treatment for pathogens requiring isolation in diseases and disorders of the circulatory system, COVID-19, virus proven;
F77B Complex treatment for pathogens requiring isolation in diseases and disorders of the circulatory system;
I26A Intensive care complex treatment >785/829/- effort points in diseases and disorders of the musculoskeletal system and connective tissue;
I26B Intensive care complex treatment >588/552/552 effort points in diseases and disorders of the musculoskeletal system and connective tissue or certain highly complex implants.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

New procedure codes to be introduced in CCAM Nomenclature published in France

Mar 2023

On March 2, 2023, the decision of the National Union of Health Insurance Funds relating to the update of the CCAM Nomenclature of procedure codes was published in the Official Journal of the French Republic. Changes include registration of new procedure codes, modification and removal of some existing codes. Newly introduced codes concern cardiovascular procedures, interventional radiology, orthopedics, peripheral vascular procedures, and others.

A new screening algorithm for preeclampsia will be covered in a clinical study setting in Norway

Mar 2023

A new preeclampsia screening algorithm has been evaluated within the "New Method" framework since 2021. The algorithm helps to predict the risk of preeclampsia in the first trimester based on several parameters, including ultrasound examination and measurement of the Placenta Growth Factor (PIGF). In March 2023, the Decision Forum for "New Method" was held and commissioned to perform the implementation study of a new screening algorithm at St. Olav's Hospital.

New codes for in-vitro diagnostics added to the Belgian Nomenclature

Mar 2023

On March 1, 2023, Belgian National Institute for Health and Disability Insurance (INAMI-RIZIV) updated three Articles of the Nomenclature related to in-vitro diagnostics. Twelve new codes concerning clinical biology, molecular biology for infections, and genetics were implemented.

The G-BA Innovation Committee published funding priorities in Germany

Mar 2023

On March 2, 2023, the Innovation Committee at the Federal Joint Committee (G-BA) published the determined funding priorities for new forms of care. A total of six prioritized topics are defined. The preparation of a complete application can be supported for a period of up to six months with a grant of up to a maximum of €75,000. The deadline for submitting ideas is May 16, 2023.

Recently published medtech-related HTAs in Wales

Mar 2023

In January-February 2023, Health Technology Wales published sixteen Medtech-related Topic Exploration Reports (TER), including stereotactic radiosurgery, percutaneous implantation of pulmonary artery pressure sensors, ambulatory patch ECG devices, and others; however, Health Technology Wales will not proceed with full appraisals on these topics. No Guidance was released for Medtech in January-February 2023.